Population pharmacokinetic modeling of dolutegravir/lamivudine to support a once-daily fixed-dose combination regimen in virologically suppressed adults living with HIV-1

This study is registered with ClinicalTrials.gov as NCT03446573.PMID:38587380 | DOI:10.1128/aac.01504-23

Source: Antimicrobial Agents and Chemotherapy - April 8, 2024 Category: Microbiology Authors: Hardik Chandasana Rajendra Singh Kimberly Adkison Mounir Ait-Khaled Teodora Pene Dumitrescu Source Type: research